Anna Bunker
Neurology with Special Qualifications in Child Neurology · Athens, GANPI 1376961565
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,826 of the $3,243 with a category attached, or 87.1%. 28 manufacturers reported payments, led by Livanova USA, Inc. at 29.1% of the total. Reporting peaked in 2024 at $2,176 and has fallen 80.7% since, to $420 in 2025.
Across 111 payments — averaging $29.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$943
- Neurelis, Inc.$640
- UCB, Inc.$363
- Jazz Pharmaceuticals Inc.$247
- AbbVie$141
- Acadia Pharmaceuticals Inc$110
- plus $800 from 22 others
What the payments were for
- Travel & lodging$39812%
- Food & beverage$2,82687%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 6 | $943 |
| Neurelis, Inc. | 30 | $640 |
| UCB, Inc. | 18 | $363 |
| Jazz Pharmaceuticals Inc. | 5 | $247 |
| AbbVie(2 entities) | 7 | $141 |
| Acadia Pharmaceuticals Inc | 5 | $110 |
| Ipsen Biopharmaceuticals, Inc | 5 | $95 |
| Immedica Pharma US, Inc. | 5 | $95 |
| Ironshore Pharmaceuticals Inc. | 3 | $71 |
| Biocodex, Inc. | 1 | $69 |
| Baxter Healthcare | 3 | $65 |
| Mallinckrodt Hospital Products Inc. | 3 | $51 |
| AstraZeneca | 3 | $51 |
| Lundbeck LLC | 2 | $31 |
| Sobi, Inc | 1 | $30 |
| Amgen(2 entities) | 2 | $29 |
| Merz North America, Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Greenwich Biosciences, Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $19 |
| Merck | 1 | $18 |
| Adamas Pharmaceuticals, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Aprecia Pharmaceuticals, LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Aquestive Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$877
- Epidiolex$148
- VALTOCO$101
How this compares
$3,243 in reported general payments places this provider in the 60th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Other neurology with special qualifications in child neurology in Athens
- Eugene MorrisAthens$3K
- John HemphillSavannah$2M
- Chaouki KhouryAtlanta$978K
- Katherine MoretzSavannah$144K
- Yong ParkAugusta$78K
- Daniel TarquinioGainesville$50K
- Han PhanAtlanta$44K
- Raymond ChengAtlanta$40K
- Sonam BhallaAtlanta$23K
- Cherise FrazierAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.